[en] The protease ADAMTS7 functions in the extracellular matrix (ECM) of the cardiovascular system. However, its physiological substrate specificity and mechanism of regulation remain to be explored. To address this, we conducted an unbiased substrate analysis using terminal amine isotopic labeling of substrates (TAILS). The analysis identified candidate substrates of ADAMTS7 in the human fibroblast secretome, including proteins with a wide range of functions, such as collagenous and non-collagenous ECM proteins, growth factors, proteases, and cell-surface receptors. It also suggested that autolysis occurs at Glu729-Val730 and Glu732-Ala733 in the ADAMTS7 spacer domain, which was corroborated by N-terminal sequencing and western blotting. Importantly, TAILS also identified proteolysis of the latent TGF-β-binding proteins 3 and 4 (LTBP3/4) at a Glu-Val and Glu-Ala site, respectively. Using purified enzyme and substrate, we confirmed ADAMTS7-catalyzed proteolysis of recombinant LTBP4. Moreover, we identified multiple additional scissile bonds in an N-terminal linker region of LTBP4 that connects fibulin-5/tropoelastin and fibrillin-1-binding regions, which have an important role in elastogenesis. ADAMTS7-mediated cleavage of LTBP4 was efficiently inhibited by the metalloprotease inhibitor TIMP-4, but not by TIMP-1 and less efficiently by TIMP-2 and TIMP-3. As TIMP-4 expression is prevalent in cardiovascular tissues, we propose that TIMP-4 represents the primary endogenous ADAMTS7 inhibitor. In summary, our findings reveal LTBP4 as an ADAMTS7 substrate, whose cleavage may potentially impact elastogenesis in the cardiovascular system. We also identify TIMP-4 as a likely physiological ADAMTS7 inhibitor.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Colige, Alain ; Université de Liège - ULiège > GIGA-Cancer > Laboratory of Connective Tissues Biology
Monseur, Christine ; Université de Liège - ULiège > GIGA > Laboratory of Connective Tissue Biology
Crawley, JTB; Imperial College London, United Kingdom. > Haematology
Santamaria, S; Imperial College London, United Kingdom.
de Groot, Rens; Imperial College London, United Kingdom. > Centre for Haematology
Language :
English
Title :
Proteomic discovery of substrates of the cardiovascular protease ADAMTS7.
Publication date :
29 March 2019
Journal title :
Journal of Biological Chemistry
ISSN :
0021-9258
eISSN :
1083-351X
Publisher :
American Society for Biochemistry and Molecular Biology, United States - Maryland
Somerville, R. P., Longpré, J. M., Apel, E. D., Lewis, R. M., Wang, L. W., Sanes, J. R., Leduc, R., and Apte, S. S. (2004) ADAMTS7B, the full-length product of the ADAMTS7 gene, is a chondroitin sulfate proteoglycan containing a mucin domain. J. Biol. Chem. 279, 35159-35175
Gomis-Rüth, F. X. (2009) Catalytic domain architecture of metzincin metalloproteases. J. Biol. Chem. 284, 15353-15357
Gendron, C., Kashiwagi, M., Lim, N. H., Enghild, J. J., Thøgersen, I. B., Hughes, C., Caterson, B., and Nagase, H. (2007) Proteolytic activities of human ADAMTS-5: Comparative studies with ADAMTS-4. J. Biol. Chem. 282, 18294-18306
de Groot, R., Bardhan, A., Ramroop, N., Lane, D. A., and Crawley, J. T. (2009) Essential role of the disintegrin-like domain in ADAMTS13 function. Blood 113, 5609-5616
de Groot, R., Lane, D. A., and Crawley, J. T. (2015) The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis. Blood 125, 1968-1975
Reilly, M. P., Li, M., He, J., Ferguson, J. F., Stylianou, I. M., Mehta, N. N., Burnett, M. S., Devaney, J. M., Knouff, C. W., Thompson, J. R., Horne, B. D., Stewart, A. F., Assimes, T. L., Wild, P. S., Allayee, H., et al. (2011) Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: Two genome-wide association studies. Lancet 377, 383-392
Bauer, R. C., Tohyama, J., Cui, J., Cheng, L., Yang, J., Zhang, X., Ou, K., Paschos, G. K., Zheng, X. L., Parmacek, M. S., Rader, D. J., and Reilly, M. P. (2015) Knockout of Adamts7, a novel coronary artery disease locus in humans, reduces atherosclerosis in mice. Circulation 131, 1202-1213
Wang, L., Zheng, J., Bai, X., Liu, B., Liu, C. J., Xu, Q., Zhu, Y., Wang, N., Kong, W., and Wang, X. (2009) ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries. Circ. Res. 104, 688-698
Bengtsson, E., Hultman, K., Dunér, P., Asciutto, G., Almgren, P., Orho-Melander, M., Melander, O., Nilsson, J., Hultgårdh-Nilsson, A., and Gonçalves, I. (2017) ADAMTS-7 is associated with a high-risk plaque phenotype in human atherosclerosis. Sci. Rep. 7, 3753
Kessler, T., Zhang, L., Liu, Z., Yin, X., Huang, Y., Wang, Y., Fu, Y., Mayr, M., Ge, Q., Xu, Q., Zhu, Y., Wang, X., Schmidt, K., de Wit, C., Erdmann, J., Schunkert, H., Aherrahrou, Z., and Kong, W. (2015) ADAMTS-7 inhibits re-endothelialization of injured arteries and promotes vascular remodeling through cleavage of thrombospondin-1. Circulation 131, 1191-1201
Mead, T. J., McCulloch, D. R., Ho, J. C., Du, Y., Adams, S. M., Birk, D. E., and Apte, S. S. (2018) The metalloproteinase-proteoglycans ADAMTS7 and ADAMTS12 provide an innate, tendon-specific protective mechanism against heterotopic ossification. JCI Insight 3, 92941
Schunkert, H., König, I. R., Kathiresan, S., Reilly, M. P., Assimes, T. L., Holm, H., Preuss, M., Stewart, A. F., Barbalic, M., Gieger, C., Absher, D., Aherrahrou, Z., Allayee, H., Altshuler, D., Anand, S. S., et al. (2011) Largescale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43, 333-338
Pu, X., Xiao, Q., Kiechl, S., Chan, K., Ng, F. L., Gor, S., Poston, R. N., Fang, C., Patel, A., Senver, E. C., Shaw-Hawkins, S., Willeit, J., Liu, C., Zhu, J., Tucker, A. T., Xu, Q., Caulfield, M. J., and Ye, S. (2013) ADAMTS7 cleavage and vascular smooth muscle cell migration is affected by a coronaryartery-disease-associated variant. Am. J. Hum. Genet. 92, 366-374
Brew, K., and Nagase, H. (2010) The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity. Biochim. Biophys. Acta 1803, 55-71
Liu, C. J., Kong, W., Ilalov, K., Yu, S., Xu, K., Prazak, L., Fajardo, M., Sehgal, B., and Di Cesare, P. E. (2006) ADAMTS-7: A metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein. FASEB J. 20, 988-990
Kleifeld, O., Doucet, A., auf dem Keller, U., Prudova, A., Schilling, O., Kainthan, R. K., Starr, A. E., Foster, L. J., Kizhakkedathu, J. N., and Overall, C. M. (2010) Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products. Nat. Biotechnol. 28, 281-288
Longpré, J.-M., McCulloch, D. R., Koo, B.-H., Alexander, J. P., Apte, S. S., and Leduc, R. (2009) Characterization of proADAMTS5 processing by proprotein convertases. Int. J. Biochem. Cell Biol. 41, 1116-1126
Pos, W., Crawley, J. T., Fijnheer, R., Voorberg, J., Lane, D. A., and Luken, B. M. (2010) An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF. Blood 115, 1640-1649
Jin, S. Y., Skipwith, C. G., and Zheng, X. L. (2010) Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain ofADAMTS13are critical for cleavage of von Willebrand factor. Blood 115, 2300-2310
Akiyama, M., Takeda, S., Kokame, K., Takagi, J., and Miyata, T. (2009) Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor. Proc. Natl. Acad. Sci. U.S.A. 106, 19274-19279
Noda, K., Dabovic, B., Takagi, K., Inoue, T., Horiguchi, M., Hirai, M., Fujikawa, Y., Akama, T. O., Kusumoto, K., Zilberberg, L., Sakai, L. Y., Koli, K., Naitoh, M., von Melchner, H., Suzuki, S., Rifkin, D. B., and Nakamura, T. (2013) Latent TGF-beta binding protein 4 promotes elastic fiber assembly by interacting with fibulin-5. Proc. Natl. Acad. Sci. U.S.A. 110, 2852-2857
Robertson, I. B., Horiguchi, M., Zilberberg, L., Dabovic, B., Hadjiolova, K., and Rifkin, D. B. (2015) Latent TGF-binding proteins. Matrix Biol. 47, 44-53
Sterner-Kock, A., Thorey, I. S., Koli, K., Wempe, F., Otte, J., Bangsow, T., Kuhlmeier, K., Kirchner, T., Jin, S., and Keski-Oja, J. (2002) Disruption of the gene encoding the latent transforming growth factor- binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. Genes Dev. 16, 2264-2273
Arroyo, A. G., and Andrés, V. (2015)ADAMTS7in cardiovascular disease: From bedside to bench and back again? Circulation 131, 1156-1159
Fabre, B., Ramos, A., and de Pascual-Teresa, B. (2014) Targeting matrix metalloproteinases: Exploring the dynamics of the s1 pocket in the design of selective, small molecule inhibitors. J. Med. Chem. 57, 10205-10219
Müller, M., Kessler, T., Schunkert, H., Erdmann, J., and Tennstedt, S. (2016) Classification of ADAMTS binding sites: The first step toward selective ADAMTS7 inhibitors. Biochem. Biophys. Res. Commun. 471, 380-385
Desiere, F., Deutsch, E. W., King, N. L., Nesvizhskii, A. I., Mallick, P., Eng, J., Chen, S., Eddes, J., Loevenich, S. N., and Aebersold, R. (2006) The PeptideAtlas project. Nucleic Acids Res. 34, D655-D658
Doll, S., Dreßen, M., Geyer, P. E., Itzhak, D. N., Braun, C., Doppler, S. A., Meier, F., Deutsch, M. A., Lahm, H., Lange, R., Krane, M., and Mann, M. (2017) Region and cell-type resolved quantitative proteomic map of the human heart. Nat. Commun. 8, 1469
Knight, C. G. (1995) Active-site titration of peptidases. Methods Enzymol. 248, 85-101
Hubmacher, D., and Apte, S. S. (2015) ADAMTS proteins as modulators of microfibril formation and function. Matrix Biol. 47, 34-43
Cain, S. A., Mularczyk, E. J., Singh, M., Massam-Wu, T., and Kielty, C. M. (2016) ADAMTS-10 and-6 differentially regulate cell-cell junctions and focal adhesions. Sci. Reports 6, 35956
Mularczyk, E. J., Singh, M., Godwin, A. R. F., Galli, F., Humphreys, N., Adamson, A. D., Mironov, A., Cain, S. A., Sengle, G., Boot-Handford, R. P., Cossu, G., Kielty, C. M., and Baldock, C. (2018) ADAMTS10-mediated tissue disruption in Weill-Marchesani syndrome. Hum. Mol. Genet. 27, 3675-3687
Wang, L. W., Kutz, W. E., Mead, T. J., Beene, L. C., Singh, S., Jenkins, M. W., Reinhardt, D. P., and Apte, S. S. (2018) Adamts10 inactivation in mice leads to persistence of ocular microfibrils subsequent to reduced fibrillin-2 cleavage. Matrix Biol. 77, 117-128
Nicholson, A. C., Malik, S. B., Logsdon, J. M., Jr., and Van Meir, E. G. (2005) Functional evolution of ADAMTS genes: Evidence from analyses of phylogeny and gene organization. BMC Evol. Biol. 5, 11
Georgiadis, K., Crawford, T., Tomkinson, K., Shakey, Q., Stahl, M., Morris, E., Collins-Racie, L., and LaVallie, E. (2002) ADAMTS-5 is autocatalytic at a E753-G754 site in the spacer domain. in Transactions of the Annual Meeting-Orthopaedic Research Society, p. 167, Orthopaedic Research Society, Boston
Flannery, C. R., Zeng, W., Corcoran, C., Collins-Racie, L. A., Chockalingam, P. S., Hebert, T., Mackie, S. A., McDonagh, T., Crawford, T. K., Tomkinson, K. N., LaVallie, E. R., and Morris, E. A. (2002) Autocatalytic cleavage of ADAMTS-4 (Aggrecanase-1) reveals multiple glycosaminoglycan-binding sites. J. Biol. Chem. 277, 42775-42780
Hubmacher, D., Schneider, M., Berardinelli, S. J., Takeuchi, H., Willard, B., Reinhardt, D. P., Haltiwanger, R. S., and Apte, S. S. (2017) Unusual life cycle and impact on microfibril assembly of ADAMTS17, a secreted metalloprotease mutated in genetic eye disease. Sci. Rep. 7, 41871
Kashiwagi, M., Tortorella, M., Nagase, H., and Brew, K. (2001) TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J. Biol. Chem. 276, 12501-12504
Guo, C., Tsigkou, A., and Lee, M. H. (2016) ADAMTS13 and 15 are not regulated by the full-length and N-terminal domain forms of TIMP-1,-2,-3 and-4. Biomed. Rep. 4, 73-78
Rodríguez-Manzaneque, J. C., Westling, J., Thai, S. N. M., Luque, A., Knauper, V., Murphy, G., Sandy, J. D., and Iruela-Arispe, M. L. (2002) ADAMTS1cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors. Biochem. Biophys. Res. Commun. 293, 501-508
Hashimoto, G., Aoki, T., Nakamura, H., Tanzawa, K., and Okada, Y. (2001) Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4). FEBS Lett. 494, 192-195
Koskivirta, I., Rahkonen, O., Mäyränpää, M., Pakkanen, S., Husheem, M., Sainio, A., Hakovirta, H., Laine, J., Jokinen, E., Vuorio, E., Kovanen, P., and Järveläinen, H. (2006) Tissue inhibitor of metalloproteinases 4 (TIMP4) is involved in inflammatory processes of human cardiovascular pathology. Histochem. Cell Biol. 126, 335-342
Rahkonen, O. P., Koskivirta, I. M., Oksjoki, S. M., Jokinen, E., and Vuorio, E. I. (2002) Characterization of the murine Timp4 gene, localization within intron 5 of the synapsin 2 gene and tissue distribution of the mRNA. Biochim. Biophys. Acta 1577, 45-52
Koskivirta, I., Kassiri, Z., Rahkonen, O., Kiviranta, R., Oudit, G. Y., McKee, T. D., Kytö, V., Saraste, A., Jokinen, E., Liu, P. P., Vuorio, E., and Khokha, R. (2010) Mice with tissue inhibitor of metalloproteinases 4 (Timp4) deletion succumb to induced myocardial infarction but not to cardiac pressure overload. J. Biol. Chem. 285, 24487-24493
Rifkin, D. B., Rifkin, W. J., and Zilberberg, L. (2018) LTBPs in biology and medicine: LTBP diseases. Matrix Biol. 71-72, 90-99
Huckert, M., Stoetzel, C., Morkmued, S., Laugel-Haushalter, V., Geoffroy, V., Muller, J., Clauss, F., Prasad, M. K., Obry, F., Raymond, J. L., Switala, M., Alembik, Y., Soskin, S., Mathieu, E., Hemmerlé, J., et al. (2015) Mutations in the latent TGF- binding protein 3 (LTBP3) gene cause brachyolmia with amelogenesis imperfecta. Hum. Mol. Genet. 24, 3038-3049
Guo, D. C., Regalado, E. S., Pinard, A., Chen, J., Lee, K., Rigelsky, C., Zilberberg, L., Hostetler, E. M., Aldred, M., Wallace, S. E., Prakash, S. K., University of Washington Center for Mendelian Genomics, Leal, S. M., Bamshad, M. J., Nickerson, D. A., et al. (2018) LTBP3 pathogenic variants predispose individuals to thoracic aortic aneurysms and dissections. Am. J. Hum. Genet. 102, 706-712
Koski, C., Saharinen, J., and Keski-Oja, J. (1999) Independent promoters regulate the expression of two amino terminally distinct forms of latent transforming growth factor- binding protein-1 (LTBP-1) in a cell typespecific manner. J. Biol. Chem. 274, 32619-32630
Todorovic, V., Finnegan, E., Freyer, L., Zilberberg, L., Ota, M., and Rifkin, D. B. (2011) Long form of latent TGF- binding protein 1 (Ltbp1L) regulates cardiac valve development. Dev. Dyn. 240, 176-187
Todorovic, V., Frendewey, D., Gutstein, D. E., Chen, Y., Freyer, L., Finnegan, E., Liu, F., Murphy, A., Valenzuela, D., Yancopoulos, G., and Rifkin, D. B. (2007) Long form of latent TGF- binding protein 1 (Ltbp1L) is essential for cardiac outflow tract septation and remodeling. Development 134, 3723-3732
Santamaria, S., Crawley, J. T. B., Yamamoto, K., Ahnstrom, J., and de Groot, R. (2017) A comparison of COMP (TSP5) proteolysis by ADAMTS7 and ADAMTS4. Int. J. Exp. Pathol. 98, A3-A4
Bekhouche, M., Leduc, C., Dupont, L., Janssen, L., Delolme, F., Vadon-Le Goff, S., Smargiasso, N., Baiwir, D., Mazzucchelli, G., Zanella-Cleon, I., Dubail, J., De Pauw, E., Nusgens, B., Hulmes, D. J., Moali, C., and Colige, A. (2016) Determination of the substrate repertoire of ADAMTS2, 3, and 14 significantly broadens their functions and identifies extracellular matrix organization and TGF- signaling as primary targets. FASEB J. 30, 1741-1756
de Groot, R. (2019) ADAMTS7: Recombinant protein expression and purification. inADAMTSproteins. Methods in Molecular Biology (Apte, S. S., ed) Humana Press, New York, NY
Zimmermann, L., Stephens, A., Nam, S. Z., Rau, D., Kübler, J., Lozajic, M., Gabler, F., Söding, J., Lupas, A. N., and Alva, V. (2018) A completely reimplemented MPI bioinformatics toolkit with a new HHpred server at its core. J. Mol. Biol. 430, 2237-2243
Webb, B., and Sali, A. (2016) Comparative protein structure modeling using MODELLER. Curr. Protoc. Protein Sci. 86, 2.9.1-2.9.37